NAIROBI, Jan. 16 (Xinhua) -- A new drug that is expected to lower malaria transmission among pregnant women living with HIV was unveiled Tuesday by Kenya and Malawian scientists, following rigorous trials.
Through research findings published in the Lancet, a prestigious medical journal, the scientists noted that the addition of the antimalarial drug dihydroartemisinin-piperaquine to other existing medications will significantly reduce the risk of malaria infection among pregnant women who are HIV positive.
